Qualitative Drug Screen Testing 2015 Change in CPT Codes

Subscribe or sign in to view the full article.

Note:  The following article synopsis was NOT provided by BC Advantage. It was created by Find-A-Code/innoviHealth.

Article Overview

This article explains a Medicare/CMS coding update affecting qualitative drug-screen testing in the physician office setting and notes the related code-set changes for 2015. It is intended for coders, billing staff, and compliance teams who need to understand which coding families were referenced, the effective timing of the change, and the general scope of the update without relying on the full premium article.

Why This Topic Matters

The page helps readers identify whether they need to review a 2015 reporting update tied to CMS guidance for drug-screen testing. It is useful for teams managing charge capture, claims processing, and code-set transition awareness in office-based laboratory billing.

What You Will Learn

  • Which coding families were affected by the 2015 update
  • What broad reporting area the CMS change relates to
  • Which general code-set changes are referenced in the notice
  • How the article frames the timing and applicability of the update

Who Should Read This

  • Medical coders
  • Billing specialists
  • Revenue cycle staff
  • Compliance staff
  • Physician office administrators

Codes Discussed

Code Ranges Discussed

  • CPT: 80300 THROUGH 80377

Subscribe or sign in to view the full article.

Access to this feature is available in the following products:
  • BC Advantage, 30+ CEUs & Webinars

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.

Aimee- AI -powered coding assistant - Try it now for Free Would you like Aimee - AI
to help you with this?